ERBB2 and neoplasm: Previously, the expression of several miRNAs has been associated with HER2 receptor status, including miR-143, which is significantly upregulated in HER2-negative vs. HER2-positive tumors [38] and is considered as tumor-suppressing miRNA frequently downregulated in tumors (see e.g., [35,39]).